In connection with the previous agreement dispute, Hemostemix has recently announced the closure of the agreement and the settlement of all prosecution with Aspire Health Science in a very recent news release by the company itself.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.